We and others have shown that antibody blockade [1], pharmacological preconditioning [2, 3], or genetic ablation [4, 5] of toll-like receptor 2 (TLR2) signalling is protective in a mouse model of myocardial ischemia and reperfusion (MI/R). The gene discussed is TLR2; the disease is myocardial ischemia.